Beta Drugs (India) Performance
| BETA Stock | 2,172 28.40 1.32% |
On a scale of 0 to 100, Beta Drugs holds a performance score of 8. The firm shows a Beta (market volatility) of 0.56, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Beta Drugs' returns are expected to increase less than the market. However, during the bear market, the loss of holding Beta Drugs is expected to be smaller as well. Please check Beta Drugs' treynor ratio, value at risk, and the relationship between the sortino ratio and maximum drawdown , to make a quick decision on whether Beta Drugs' price patterns will revert.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Beta Drugs are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Beta Drugs unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Why Investors Shouldnt Be Surprised By Beta Drugs Limiteds 30 percent Share Price Surge - Simply Wall St | 11/07/2024 |
Beta |
Beta Drugs Relative Risk vs. Return Landscape
If you would invest 175,770 in Beta Drugs on September 2, 2024 and sell it today you would earn a total of 41,415 from holding Beta Drugs or generate 23.56% return on investment over 90 days. Beta Drugs is generating 0.3953% of daily returns and assumes 3.4883% volatility on return distribution over the 90 days horizon. Simply put, 31% of stocks are less volatile than Beta, and 93% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Beta Drugs Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Beta Drugs' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Beta Drugs, and traders can use it to determine the average amount a Beta Drugs' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1133
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BETA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.49 actual daily | 31 69% of assets are more volatile |
Expected Return
| 0.4 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Beta Drugs is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Beta Drugs by adding it to a well-diversified portfolio.
About Beta Drugs Performance
Assessing Beta Drugs' fundamental ratios provides investors with valuable insights into Beta Drugs' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Beta Drugs is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Beta Drugs is entity of India. It is traded as Stock on NSE exchange.Things to note about Beta Drugs performance evaluation
Checking the ongoing alerts about Beta Drugs for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Beta Drugs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Beta Drugs had very high historical volatility over the last 90 days | |
| Latest headline from news.google.com: Why Investors Shouldnt Be Surprised By Beta Drugs Limiteds 30 percent Share Price Surge - Simply Wall St |
- Analyzing Beta Drugs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Beta Drugs' stock is overvalued or undervalued compared to its peers.
- Examining Beta Drugs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Beta Drugs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Beta Drugs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Beta Drugs' stock. These opinions can provide insight into Beta Drugs' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Beta Stock Analysis
When running Beta Drugs' price analysis, check to measure Beta Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beta Drugs is operating at the current time. Most of Beta Drugs' value examination focuses on studying past and present price action to predict the probability of Beta Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beta Drugs' price. Additionally, you may evaluate how the addition of Beta Drugs to your portfolios can decrease your overall portfolio volatility.